5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.04▼ | 2.03▲ | 2.05▼ | 2.04▼ | 2.01▲ |
MA10 | 2.04▼ | 2.06▼ | 2.05▼ | 2.01▲ | 2.13▼ |
MA20 | 2.07▼ | 2.05▼ | 2.06▼ | 2.01▲ | 3.15▼ |
MA50 | 2.05▼ | 2.08▼ | 2.03▼ | 2.16▼ | N/A |
MA100 | 2.07▼ | 2.02▲ | 2.00▲ | 3.34▼ | N/A |
MA200 | 2.04▼ | 2.02▲ | 2.07▼ | 7.47▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.004▼ | -0.006▼ | 0.035▲ | 0.183▲ |
RSI | 43.038▼ | 45.679▼ | 46.887▼ | 46.592▼ | 33.181▼ |
STOCH | 42.857 | 24.930 | 54.433 | 64.764 | 10.451▼ |
WILL %R | -75.000▼ | -70.370 | -57.576 | -43.284 | -94.748▼ |
CCI | -65.712 | -51.415 | -34.153 | 42.972 | -59.287 |
Wednesday, June 11, 2025 11:05 PM
Research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Artiva Biotherapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer ...
|
Wednesday, May 28, 2025 01:05 PM
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...
|
Wednesday, May 14, 2025 05:00 PM
The latest price target for Artiva Biotherapeutics (NASDAQ:ARTV) was reported by Needham on May 15, 2025. The analyst firm set a price target for $18.00 expecting ARTV to rise to within 12 months ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.01 | 2.06 | 2.01 | 2.03 | 64,070 |
12/06/25 | 1.97 | 2.15 | 1.89 | 2.05 | 124,920 |
11/06/25 | 2.14 | 2.14 | 1.96 | 1.96 | 172,729 |
10/06/25 | 2.08 | 2.175 | 2.03 | 2.065 | 135,866 |
09/06/25 | 2.12 | 2.1499 | 2.07 | 2.11 | 57,484 |
06/06/25 | 1.98 | 2.14 | 1.98 | 2.10 | 212,193 |
05/06/25 | 1.97 | 2.00 | 1.915 | 1.96 | 79,961 |
04/06/25 | 1.96 | 1.99 | 1.93 | 1.97 | 72,972 |
03/06/25 | 1.9028 | 1.99 | 1.9028 | 1.95 | 120,653 |
02/06/25 | 1.97 | 1.9936 | 1.84 | 1.94 | 150,316 |
|
|
||||
|
|
||||
|
|